5 Signs That You May Need Outside Help with Your Drug Diversion Program
5 Signs That You May Need Outside Help with Your Drug Diversion Program
Every hospital today is in some stage of planning, implementing and/or managing a drug diversion…
Diversion Quarterly — Q3 2020
Kit Check is sharing data from its Bluesight™ for Controlled Substances platform on a quarterly…
Doug Zurawski in Pharmacy Times – Enter AI: How Technology is Changing the Pharmaceutical Industry for the Better
Doug Zurawski, Senior Vice President of Clinical Strategy at Kit Check, was recently published in…
Nursing during COVID-19: A Chat with AJ Rivosecchi and Carol Purcell
Kit Check’s Senior Director of Clinical Strategy AJ Rivosecchi sat down (virtually) with Carol Purcell,…
Webinar Recording: Current Perspectives and Future Trends in Diversion Detection Webinar
Recently we hosted an online symposium around the topic of diversion detection. We were honored …
Kit Check Presents Groundbreaking Drug Diversion Symposium Featuring Top Industry Leaders
Continuing education webinar addresses critical components, perspectives and best practices for hospitals, pharmacists and medical …
Bluesight for Controlled Substances featured in Quartz article about the role of tech in combating the opioid crisis
The nation is in the grip of a tragic opioid crisis, and drugs that are …
Kit Check’s Bluesight for Controlled Substances™ Recognized by KLAS as Leading Emerging Solution for Drug Diversion Monitoring
Bluesight for Controlled Substances heralded in industry report, earns rating of 93.2 out of 100 …
Webinar: The Diversion Gap and What to Do About It
Kit Check’s Clinical Solutions Specialist AJ Rivosecchi, Pharm.D., recently held a webinar to discuss what …
Nurses Unite: Impacting Change Around the Opioid Epidemic
This week we come together to celebrate the bravery, compassion, and determination of nurses. There …